Long-Term Remission of Acromegaly after Octreotide Withdrawal Is an Uncommon and Frequently Unsustainable Event-Reference-Cited by-同舟云学术

Long-Term Remission of Acromegaly after Octreotide Withdrawal Is an Uncommon and Frequently Unsustainable Event

Published:2016-05-05 Issue:3 Volume:104 Page:273-279
ISSN:0028-3835
Container-title:Neuroendocrinology
language:en
Short-container-title:Neuroendocrinology

Author:

Casagrande Alessandra,Bronstein Marcello D.,Jallad Raquel S.,Moraes Aline B.,Elias Paula C.L.,Castro Margaret,Czepielewski Mauro A.,Boschi Artur,Ribeiro-Oliveira Jr. Antonio,Schweizer Junia R.O.L.,Vilar Lucio,Nazato Debora M.,Gadelha Mônica R.,Abucham Julio,

Publisher

S. Karger AG

Subject

Cellular and Molecular Neuroscience,Endocrine and Autonomic Systems,Endocrinology,Endocrinology, Diabetes and Metabolism

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term Remission in Functioning Pituitary Adenomas after Medical Therapy Withdrawal: A Chance for Cushing’s Disease;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-07-30

2. Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine;The Journal of Clinical Endocrinology & Metabolism;2024-06-03

3. Position statement on the diagnosis and management of acromegaly: The French National Diagnosis and Treatment Protocol (NDTP);Annales d'Endocrinologie;2023-12

4. Cost-effectiveness of direct surgery versus preoperative octreotide therapy for growth-hormone secreting pituitary adenomas;Pituitary;2022-08-27

5. Persistent remission of acromegaly in a patient with GH‐secreting pituitary adenoma: Effect of treatment with pasireotide long‐acting release and consequence of treatment withdrawal;Journal of Clinical Pharmacy and Therapeutics;2022-02-15